These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 22982866)
1. Detoxification of tabun at physiological pH mediated by substituted β-cyclodextrin and glucose derivatives containing oxime groups. Brandhuber F; Zengerle M; Porwol L; Tenberken O; Thiermann H; Worek F; Kubik S; Reiter G Toxicology; 2012 Dec; 302(2-3):163-71. PubMed ID: 22982866 [TBL] [Abstract][Full Text] [Related]
2. Detoxification of nerve agents by a substituted beta-cyclodextrin: application of a modified biological assay. Wille T; Tenberken O; Reiter G; Müller S; Le Provost R; Lafont O; Estour F; Thiermann H; Worek F Toxicology; 2009 Nov; 265(3):96-100. PubMed ID: 19800384 [TBL] [Abstract][Full Text] [Related]
3. Elimination pathways of cyclosarin (GF) mediated by β-cyclodextrin in vitro: pharmacokinetic and toxicokinetic aspects. Kranawetvogl A; Schüler J; Müller S; Thiermann H; Worek F; Reiter G Toxicol Lett; 2013 Oct; 222(2):164-70. PubMed ID: 23906718 [TBL] [Abstract][Full Text] [Related]
4. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Kassa J; Karasova J; Musilek K; Kuca K Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821 [TBL] [Abstract][Full Text] [Related]
5. New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (I). Synthesis and preliminary screening: evaluation of the detoxification using a half-quantitative enzymatic assay. Kalakuntla RK; Wille T; Le Provost R; Letort S; Reiter G; Müller S; Thiermann H; Worek F; Gouhier G; Lafont O; Estour F Toxicol Lett; 2013 Feb; 216(2-3):200-5. PubMed ID: 23201439 [TBL] [Abstract][Full Text] [Related]
6. A comparison of neuroprotective efficacy of the oxime K203 and its fluorinated analogue (KR-22836) with obidoxime in Tabun-poisoned rats. Kassa J; Karasova JZ; Tesarova S; Musilek K; Kuca K; Jung YS Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):861-7. PubMed ID: 22545968 [TBL] [Abstract][Full Text] [Related]
7. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates. Ekström F; Pang YP; Boman M; Artursson E; Akfur C; Börjegren S Biochem Pharmacol; 2006 Aug; 72(5):597-607. PubMed ID: 16876764 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats. Kassa J; Karasova J Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392 [TBL] [Abstract][Full Text] [Related]
9. Detoxification of alkyl methylphosphonofluoridates by an oxime-substituted β-cyclodextrin--an in vitro structure-activity study. Bierwisch A; Zengerle M; Thiermann H; Kubik S; Worek F Toxicol Lett; 2014 Jan; 224(2):209-14. PubMed ID: 24185128 [TBL] [Abstract][Full Text] [Related]
10. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques. Bajgar J; Hajek P; Zdarova JK; Kassa J; Paseka A; Slizova D; Krs O; Kuca K; Jun D; Fusek J; Capek L J Enzyme Inhib Med Chem; 2010 Dec; 25(6):790-7. PubMed ID: 21054236 [TBL] [Abstract][Full Text] [Related]
11. The evaluation of the reactivating and therapeutic efficacy of three novel bispyridinium oximes (K454, K456, K458) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice. Kassa J; Sepsova V; Musilek K; Horova A Toxicol Mech Methods; 2013 Feb; 23(2):94-8. PubMed ID: 22901042 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the potency of two novel bispyridinium oximes (K456, K458) in comparison with oxime K203 and trimedoxime to counteract tabun-induced neurotoxicity in rats. Kassa J; Misik J; Karasova JZ Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):201-8. PubMed ID: 23647829 [TBL] [Abstract][Full Text] [Related]
13. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds. Maxwell DM; Brecht KM; Sweeney RE Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773 [TBL] [Abstract][Full Text] [Related]
14. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice. Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085 [TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship? Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice. Kassa J; Karasova J; Bajgar J; Kuca K; Musilek K; Kopelikova I J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1040-4. PubMed ID: 19552519 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods. Kuca K; Cabal J; Kassa J Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060 [TBL] [Abstract][Full Text] [Related]
18. A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats. Kassa J; Misik J; Karasova JZ Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):333-8. PubMed ID: 22536919 [TBL] [Abstract][Full Text] [Related]
19. Multi-stage tandem mass spectrometric analysis of novel β-cyclodextrin-substituted and novel bis-pyridinium gemini surfactants designed as nanomedical drug delivery agents. Donkuru M; Chitanda JM; Verrall RE; El-Aneed A Rapid Commun Mass Spectrom; 2014 Apr; 28(7):757-72. PubMed ID: 24573807 [TBL] [Abstract][Full Text] [Related]
20. Syntheses and in vitro evaluations of uncharged reactivators for human acetylcholinesterase inhibited by organophosphorus nerve agents. Renou J; Mercey G; Verdelet T; Păunescu E; Gillon E; Arboléas M; Loiodice M; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY Chem Biol Interact; 2013 Mar; 203(1):81-4. PubMed ID: 23111374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]